Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pedersen-Bjergaard

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Ugeskrift for Laeger|August 5, 1985
[Possible etiologic significance of specific chromosome abnormalities and proto-oncogenes in malignant diseases in man]J Pedersen-Bjergaard, P Andersson, P Philip
Scandinavian Journal of Haematology|April 1, 1977
Blastic transformation of chronic myelocytic leukaemia. Clinical manifestations, prognostic factors and results of therapyJ Pedersen-Bjergaard, A M Worm, B Hainau
Scandinavian Journal of Haematology|July 1, 1978
Severe aplastic anaemia with complete autologous marrow reconstitution following treatment with antithymocyte globulin. Report of a case and review of the literatureJ Pedersen-Bjergaard, P Ernst, N I Nissen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitorsJ Pedersen-Bjergaard, M K Andersen, B Johansson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?M Dissing, M M Le Beau, J Pedersen-Bjergaard
Leukemia|December 25, 2004
Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AMLM K Andersen, D H Christiansen, J Pedersen-Bjergaard
Leukemia|October 27, 1997
High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedureJ Pedersen-Bjergaard, M Pedersen, J Myhre, et al.
Leukemia|September 13, 2003
Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemiaD H Christiansen, M K Andersen, J Pedersen-Bjergaard
Blood|May 29, 2000
Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantationJ Pedersen-Bjergaard, M K Andersen, D H Christiansen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosisD H Christiansen, M K Andersen, J Pedersen-Bjergaard
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Ugeskrift for Laeger|August 5, 1985
[Possible etiologic significance of specific chromosome abnormalities and proto-oncogenes in malignant diseases in man]J Pedersen-Bjergaard, P Andersson, P Philip
Scandinavian Journal of Haematology|April 1, 1977
Blastic transformation of chronic myelocytic leukaemia. Clinical manifestations, prognostic factors and results of therapyJ Pedersen-Bjergaard, A M Worm, B Hainau
Scandinavian Journal of Haematology|July 1, 1978
Severe aplastic anaemia with complete autologous marrow reconstitution following treatment with antithymocyte globulin. Report of a case and review of the literatureJ Pedersen-Bjergaard, P Ernst, N I Nissen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitorsJ Pedersen-Bjergaard, M K Andersen, B Johansson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?M Dissing, M M Le Beau, J Pedersen-Bjergaard
Leukemia|December 25, 2004
Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AMLM K Andersen, D H Christiansen, J Pedersen-Bjergaard
Leukemia|October 27, 1997
High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedureJ Pedersen-Bjergaard, M Pedersen, J Myhre, et al.
Leukemia|September 13, 2003
Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemiaD H Christiansen, M K Andersen, J Pedersen-Bjergaard
Blood|May 29, 2000
Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantationJ Pedersen-Bjergaard, M K Andersen, D H Christiansen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosisD H Christiansen, M K Andersen, J Pedersen-Bjergaard
Pageof 10